chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sharp needle pain in chest with standing up and laying down; 1st dose of the Moderna vaccine on 16-Aug-2021 & 2nd dose of the Moderna vaccine on 03-Sep-2021; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (sharp needle pain in chest with standing up and laying down) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna vaccine on 16-Aug-2021 & 2nd dose of the Moderna vaccine on 03-Sep-2021) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049E21A and 033D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Sep-2021, the patient experienced CHEST PAIN (sharp needle pain in chest with standing up and laying down) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna vaccine on 16-Aug-2021 & 2nd dose of the Moderna vaccine on 03-Sep-2021). The patient was treated with PARACETAMOL (TYLENOL) for Chest pain, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Chest pain, at an unspecified dose and frequency. On 03-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna vaccine on 16-Aug-2021 & 2nd dose of the Moderna vaccine on 03-Sep-2021) had resolved. At the time of the report, CHEST PAIN (sharp needle pain in chest with standing up and laying down) outcome was unknown.            Concomitant product use was not provided by the reporter
102 fever, chills, headache, body and joint aches, soreness in injection site,racing pulse
Patient presented to the ED on 2/4/21 with NSTEMI and was subsequently hospitalized. She also presented to the ED and was subsequently hospitalized on 2/24/21. These visit were within 6 weeks of receiving COVID vaccination.
Information has been received from a physician concerning a female who was vaccinated with Gardasil (lot # not reported), 0.5mL, intramuscularly.  Concomitant therapy included Menactra.  The patient fainted after receiving her Gardasil injection, date not reported.  No laboratory studies were performed.  The patient recovered on the "same day the vaccine was given".  Unspecified medical attention was sought.  Additional information has been requested.
1.5 cm area of erythemia around injection site on right arm, area swollen and tender to elbow.  Pain under axilla
1-2 days after receiving Td developed deep inside muscle. Pain right deltoid. This extended into right forearm. Continued to have this on 7/9/04. Saw nurse pract. She called office on 7/9/04 to report. No temp-no other symptoms.
Patient was administered his first dose of the Pfizer COVID vaccine in a TCU on 1/4/2021. He then returned back to his place of residence which is a skilled nursing facility. Our pharmacy had a scheduled COVID Vaccine Clinic with his skilled nursing facility for 1/12/21. The patient was included in this clinic and received a dose of the Moderna vaccine that day.  We thought this was his first dose because he stated on his pre-vaccination questionnaire that he hadn't received a COVID vaccine previously.  His nursing staff contacted us on 1/15/21 stating the patient's family told them he had received the Pfizer vaccine in his TCU. The nursing facility then contacted us to pass on this information. At this point, patient hasn't experienced adverse effects from either dose.
runny nose; "expectorant" sensation in his throat; producing a flehm, kind of like a sinus infection type thing; soreness in the arm; felt unconfirmable; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiration date: unknown), via an unknown route of administration on Jan2021 as unknown single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date in Jan2021, the patient reported that he had a shot about 8 days ago, it was Thursday last week (as reported), early in the morning and he had just soreness of arm and felt uncomfortable. But 8 days after, he experienced runny nose and an "expectorant" sensation in his throat. He wants to know if this is a side effect observed with the vaccine since he was not able to find any information on it in the literature. But on 04Feb2021 (yesterday as reported) and on 05Feb2021 (today as reported) he was developing like a runny nose and was producing flehm, kind of like a sinus infection type thing, he was not sure if people have been experiencing this. He said he just wanted to see, he doesn't know if it was a Pfizer or if he just picked up a cold. Outcome of events was unknown.   Follow-up attempts are completed. No further information is expected.
5PM screaming started, temp 104 R; 7PM seen at ER given APAP & tepid bath & oral hydration-4oz;  screaming total 7 hrs;
Patient is fully vaccinated.  COVID + 1/18/2022.  58yo F with PMHx of anxiety, asthma, DDD, depression, DM, fibromyalgia, HTN, hypothyroidism, SLE and migraines presents with dizziness. Pt reports repeated episodes of lightheadedness in the last several days. Yesterday, she felt light headed while walking in her home when she fell, hit her head on dresser. Denies LOC or blood thinner use.No nausea, vomiting, fever, chest pain, shortness of breath or focal deficits reported. In the ER, CT head along with CT of the C, T and L spine were negative for acute processes. CTAP was negative for acute processes. CXR was negative. Labs obtained were unremarkable. EKG was negative for acute ischemia. Troponins negative. D dimer is elevated. DVT prophylaxis with Heparin SubQPt treated with migraine cocktail and IVF fluids with moderate improvement. Pt discharged home.
Heart Palpitations, unexplained weight loss of 20 pounds, Hepatitis C reactivation, Lump on chest which turned out to be Stage 3 Breast Cancer. Echo and Stress Echo, treated Hepatitis C with Mavyret, chronic hematuria, three lumpectomies, Chemotherapy. Still can't move my R thumb and middle finger, first joint not working. Muscle wasting, muscle and nerve pain throughout my body, numbness in toes and fingers, taking Norco throughout the day every day. through the extreme pain was given muscle relaxers too. Still not better.
Excellent health prior to 1st vaccine & avid runner. Three Vaccines given Oct 1999-May 2000.  Developed migraine 3 days after 1st vaccine (ill for 3 days). Joint & muscle aches.Was told that this was normal for this vaccine. In March 2001, diagnosed with Hypothyroidism, osteoarthritis, & early menopause: May 2002, diagnosed with Fibromyalgia (diagnosed by 3 Rheumatologists):Feb 2003, diagnosed with Gastritis. Eyes deteriorating, continuous joint and muscle pain (debilitating at times),Abdominal pain, constipation, headaches. Medications: Levothyroxine, Paxil, Darvocet, Diclofenac, Ambien, Nexium.
patient drank less fluid, patient refused to drink; This spontaneous report was received from the physician and refers to a 12-month-old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant medications included Vitamin D.   On 22-DEC-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot #U019286, expiration date: 15-DEC-2022, administered subcutaneously for prophylaxis (strength and site of administration was not provided). Albumin status for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) has been verified as recombinant human albumin (rHA)  On the night of 22-DEC-2021, the patient's mother noted that the patient drank less fluid, and on 23-DEC-2021 the patient refused to drink (considered as fluid intake reduced). The patient was still eating during this time. The patient's mother called the physician's office on 28-DEC-2021 because the patient still refused to drink. The physician saw the patient in the office on 28-DEC-2021, gave her "PEDIALYTE" for oral rehydration, and sent the patient home. The physician said the patient was seen again in the office the morning of 29-DEC-2021, and she continued to refuse to drink. The physician tested the patient for Covid on 29-DEC-2021, and the result was negative. The physician explained the patient started to drink more throughout the day on 29-DEC-2021. The physician reported the patient was fine and back to regular fluid intake on 30-DEC-2021. On that day, the patient recovered from the event fluid intake reduced. No additional information was provided.  The causal relationship between the event of fluid intake reduced and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was not reported.
Starting 1.5 days after injection, patient experienced mild fever for 4 days peaking at 100.8F on 3rd day after injection.  Very dry mouth and rectum (with difficulty going to the bathroom).  Sore throat starting on 3rd day after injection to 5th day after injection.  Mild shortness of breath on fifth day after injection, General fatigue and dizziness throughout for 5 days.
Information has been received from a registered nurse concerning a 3-year-old male with no pre-existing allergies, birth defects or medical conditions who on 06-JUL-2005 was vaccinated subcutaneously in the left arm with a first dose of varicella virus vaccine live (Oka/Merck) (lot # 647960/0070R). There was no concomitant medication. There was no illness at the time of vaccination. On 25-MAY-2007, the patient was seen in the physician's office with 11-12 lesions on his neck and hairline. He was treated with Benadryl, Motrin and Aveeno Bath. There were no diagnostic or laboratory testes performed. The patient recovered. Additional information is not available.
Dose 1: Given on 9-3-2020. I experienced extreme chills for 7 hours the first night, fever of 101, head pain, body aches, joint pain, shooting pains from neck into head, injection site soreness, and exhaustion. I was not able to work for 8 days as these symptoms continued. On day 5 a hot, inflamed, red, raised rash 3" diameter on left arm where injection site was and I experienced exhaustion, headaches, nausea, and sinus infection like symptoms. Dr. ordered a PCR COVID-19 test, which was negative. By 9-12-2020 the headaches, body aches and rash were gone, but I still had sinus infections symptoms.   Please note that Singular 10 mg was discontinued on 8/9/2020 and I was still experiencing withdrawal symptoms through December 2020.
One hour after vaccine administered patient developed headache and became lightheaded. Patient stated he felt better after 1-2 hours.
acute kidney failure; Membranous nephropathy; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 34 year-old male patient received bnt162b2 (BNT162B2), administration date 02Nov2021 (Batch/Lot number: unknown) at the age of 33 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Non-smoking" (unspecified if ongoing); "No/non-functioning, spleen or kidney failure: Checked" (unspecified if ongoing); "No/non-functioning, spleen or kidney failure: Checked" (unspecified if ongoing); "exercise and eat healthy" (unspecified if ongoing); "Weakened immune system" (unspecified if ongoing). The patient was a non-smoking, non-alcoholic dealer and exercise and eat healthy. He had no family history of acute immune disease or kidney failure in either parent family history. None prior vaccination (within 4 weeks). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, Anatomical site of the injection: left arm, Lot number: EN6208), administration date: 16Mar2021, when the patient was 33 years old, for COVID-19 immunization, reaction(s): "covid test date=17Aug2021 / covid test result=Positive 17-AUG-2021", "covid test date=17Aug2021 / covid test result=Positive 17-AUG-2021", "Protein urine present", "kidney issues", "edema issues", "high cholesterol", "fatigue"; Bnt162b2 (dose 2, Anatomical site of the injection: left arm, Lot number: EW0161), administration date: 03May2021, when the patient was 33 years old, for COVID-19 immunization, reaction(s): "covid test date=17Aug2021 / covid test result=Positive 17-AUG-2021", "covid test date=17Aug2021 / covid test result=Positive 17-AUG-2021". The following information was reported: ACUTE KIDNEY INJURY (medically significant) with onset 25Nov2021, outcome "recovering", described as "acute kidney failure"; GLOMERULONEPHRITIS MEMBRANOUS (medically significant) with onset 25Nov2021, outcome "recovering", described as "Membranous nephropathy". The events "acute kidney failure" and "membranous nephropathy" were evaluated at the physician office visit. Therapeutic measures were taken as a result of acute kidney injury, glomerulonephritis membranous, reported as RX drug for kidney failure. Clinical details: Twenty three days after taking vaccine his kidney began to show signs of failure. His kidney failure accelerated over on 25Nov2021. He had water retention, fluid build and protein spilling into urine. He was seeing a nephrologist now and have been diagnosed with acute kidney failure caused by an autoimmune event. Membrane nephropathy.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Per mom patient came down with a fever and patient started having convulsions that lasted for about 10 minutes, mother called paramedics as this was happening, they took her to hospital and the providers at the hospital diagnosed the patient with febrile seizures. Providers at the hospital also did blood work and urine work per mom. No xrays were done. Per mom providers at the hospital informed her to make an appointment with PCP and made an apportionment with us today (02/28/2020) and informed her to have PCP possibly make a referral to a neurologist. No further treatment was done; mother did not bring ER papers with her to PCP appointment.
nausea vomitting chills fever 103 muscle aches horrible rash body felt like i was on fire has messed up my leg i cant walk its been 3 days now and the pain is off the charts i still have rash and low grade fever my leg has me concerned this is not normal u have not done enough research on this shot with ppl with my health issues and i pray it dont cost me my life over this
Initial shot did not even feel it. then a coldness in my shoulder. down my arm to wrist and up to my cheek behind my left eye, then over my sinus cavity to the right side behind my eye and to my ear.  Got home from work and noticed my left side was kind of swollen. chest and back. It felt a bit like a bee sting. I slept on my left side. Woke up with numbness on my whole left side. face was numb. My wife said it was kind of like bells palsy. Face kind of twitched a bit. Hip was numb walking was slow and I was careful as I went to the grocery store . It kind of leveled out but stayed numb all of work. I was still swollen after work.   Woke up on Sunday and my arm was hurting bad. numbness had dissipated.   ate then suddenly felt flush and hot. fetal position on the bed for a half hour then I had to drag myself to work. felt bad the first few hours but as the night went on I felt better.   I could always feel it behind my eyes. early on it felt like I was discharging a bunch of stuff from them. My body was literally numb on the left half. I could feel the middle of myself from my scalp to my toes.
Continued redness, bump, and itchiness at site of Fluzone Intradermal Influenza Virus Vaccine for 4 months after administration.
SUSPECTED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 33 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: drug allergy (Not specified), and other pre-existing medical conditions included: Patient was not pregnant at the time of reporting. Patient had no relevant medical history and concurrent conditions. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1808609, expiry: unknown) dose was not reported, 1 total, administered on 19-MAR-2021 to left arm for covid-19 prophylaxis. Age at time of vaccination 31 years old. Concomitant medications included fluoxetine, and norethisterone.  It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received non-company suspect vaccine included: Pfizer biontech covid-19 vaccine (tozinameran) (dose number in series 2) (form of admin, and route of admin were not reported, batch number: FF2590, expiry: unknown) dose was not reported, administered on 24-OCT-2021 to left arm for covid-19 prophylaxis. It was unknown whether patient had any adverse event following vaccination with Pfizer biontech covid-19 vaccine (tozinameran) (dose number in series 2). The patient additionally received non-company suspect vaccine included: Moderna covid-19 vaccine (elasomeran) (dose number in series 3) (form of admin, and route of admin were not reported, batch number: AS7145B, expiry: unknown) dose was not reported, administered on 10-SEP-2022 15:15 to left arm for covid-19 prophylaxis which was revaccination with different covid-19 vaccine (dose number in series 3).  On an unspecified date, the patient experienced covid-19 infection (suspected covid-19 infection) (dose number in series 3) for which patient received non-company suspect drug included: Paxlovid (nirmatrelvir/ritonavir) (form of admin, route of admin, and batch number were not reported, expiry: unknown) dose and frequency were not reported from 01-FEB-2023 to 06-FEB-2023 for covid-19 treatment. On 10-FEB-2023, at 18:30, the patient experienced rebound covid-19. The action taken with covid-19 vaccine ad26.cov2.s, tozinameran, and elasomeran was not applicable; and action taken with nirmatrelvir/ritonavir was not reported. The patient was recovering from suspected covid-19 infection, and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious.
2nd vaccine dose given on 02/16/2021, admitted to hospital on 02/24/2021  CARDIAC ARREST RECTAL BLEEDING died on 03/03/2021
pt recvd vax & w/in 24hrs exp a t104 & muscle aches;sx resolved w/o treatment;
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-May-2021 at 4:06 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 24-May-2021 at 4:06 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 79.99 for dose administered on 24-May-2021.  No concomitant medications were reported.  Batch number 026C21A underwent temperature excursion on 24-May-2021with temperature 35 degrees Fahrenheit from 08:00 AM to 09:00 AM. This vial was moved to fridge on 18-MAY-2021 and beyond use date for the vial was reported as 17-JUN-2021. Product moved to clinic on 24-MAY-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.
I had the latest Pfizer vaccine; after 7 days of having the vaccine I got the Covid; I had the latest Pfizer vaccine; after 7 days of having the vaccine I got the Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 26Sep2023 at 03:30 as dose 6 (booster), single (Lot number: HH7595) at the age of 69 years for covid-19 immunisation; bnt162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown) and as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure high" (ongoing). Concomitant medication(s) included: OLMESARTAN MEDOXOMIL taken for hypertension. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 04Oct2023 at 03:30, outcome "not recovered" and all described as "I had the latest Pfizer vaccine; after 7 days of having the vaccine I got the Covid". The event "i had the latest pfizer vaccine; after 7 days of having the vaccine i got the covid" required emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Oct2023) Positive, notes: I woke up with Covid which I now got tested today and confirmed. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course was reported as follows: patient reported symptoms occurred 7 and half days after vaccination. On Wednesday, when she woke up she only had a cold that got worsened, in the day of the report she reported it got worse and she woke up in the middle of night sick and in the morning was sick and she went to urgent care where she got all kinds of medicines. Azithromycin 250 mg tablet, 6 pack normally Z pack 2 that day and then she took one by mouth each day for the next 4 days, altogether it was 6 tablets. Other medication was Prednisone 20 milligrams, 2 that day and 2 tablets each morning for 3 days and they told she to take Advil if she need it. She reported she got all the vaccines 1,2,3,4,5, 6 all Pfizer and she had Covid 3 times.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.